The EUDA’s latest analysis of the European drug phenomenon reveals a drug market that is both resilient and influenced by developments taking place at the global level. The continuing health and security problems presented by established and newer illicit drugs, and increasingly the interplay between them, create a challenging policy context for the shaping and implementation of effective responses. The European Drug Report 2025 provides a snapshot of the drug situation in Europe based on the latest data available. This introductory section provides an analytical commentary on some of the important issues that are currently featuring on Europe’s drug policy agenda.

This page is part of the European Drug Report 2025, the EUDA’s annual overview of the drug situation in Europe.